Ken Griffin Health Catalyst, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,500 shares of HCAT stock, worth $123,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,500

Previous 5,900 145.76%

Holding current value

$123,250

Previous $37,000 218.92%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.48 - $8.83 $89,866 - $144,803	16,399 Added 10.29%	175,691 $1.43 Million
Q2 2024 Aug 14, 2024	SELL	$5.53 - $7.28 $269,847 - $355,242	-48,797 Reduced 23.45%	159,292 $1.02 Million
Q1 2024 May 15, 2024	SELL	$7.44 - $11.21 $250,125 - $376,868	-33,619 Reduced 13.91%	208,089 $1.57 Million
Q4 2023 Feb 14, 2024	BUY	$6.71 - $10.16 $1.08 Million - $1.64 Million	161,124 Added 199.95%	241,708 $2.24 Million
Q3 2023 Nov 14, 2023	BUY	$9.35 - $14.32 $623,467 - $954,871	66,681 Added 479.62%	80,584 $815,000
Q2 2023 Aug 14, 2023	SELL	$9.86 - $13.12 $4.52 Million - $6.02 Million	-458,744 Reduced 97.06%	13,903 $173,000
Q1 2023 May 15, 2023	SELL	$10.23 - $14.76 $3.99 Million - $5.75 Million	-389,814 Reduced 45.2%	472,647 $5.52 Million
Q4 2022 Feb 14, 2023	SELL	$6.86 - $11.32 $850,475 - $1.4 Million	-123,976 Reduced 12.57%	862,461 $9.17 Million
Q3 2022 Nov 14, 2022	BUY	$9.3 - $18.27 $1.24 Million - $2.43 Million	132,866 Added 15.57%	986,437 $9.57 Million
Q2 2022 Aug 15, 2022	BUY	$11.79 - $27.63 $4.48 Million - $10.5 Million	380,036 Added 80.26%	853,571 $12.4 Million
Q1 2022 May 16, 2022	BUY	$20.67 - $40.33 $9.4 Million - $18.3 Million	454,723 Added 2417.2%	473,535 $12.4 Million
Q4 2021 Feb 14, 2022	SELL	$36.68 - $54.02 $564,725 - $831,691	-15,396 Reduced 45.01%	18,812 $745,000
Q3 2021 Nov 15, 2021	SELL	$49.57 - $58.15 $1.84 Million - $2.16 Million	-37,139 Reduced 52.05%	34,208 $1.71 Million
Q2 2021 Aug 16, 2021	SELL	$47.17 - $58.64 $1.17 Million - $1.46 Million	-24,867 Reduced 25.85%	71,347 $3.96 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $54.07 $4.51 Million - $5.74 Million	-106,209 Reduced 52.47%	96,214 $4.5 Million
Q4 2020 Feb 16, 2021	BUY	$31.9 - $44.89 $616,786 - $867,948	19,335 Added 10.56%	202,423 $8.81 Million
Q3 2020 Nov 16, 2020	BUY	$28.55 - $36.91 $4.92 Million - $6.37 Million	172,501 Added 1629.37%	183,088 $6.7 Million
Q2 2020 Aug 14, 2020	BUY	$24.0 - $32.87 $42,336 - $57,982	1,764 Added 19.99%	10,587 $309,000
Q1 2020 May 15, 2020	BUY	$17.8 - $37.6 $157,049 - $331,744	8,823 New	8,823 $230,000
Q4 2019 Feb 14, 2020	SELL	$26.44 - $40.63 $1.5 Million - $2.3 Million	-56,687 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$30.31 - $48.63 $1.72 Million - $2.76 Million	56,687 New	56,687 $1.79 Million

Others Institutions Holding HCAT

# of Institutions

170

Shares Held

49.7M

Call Options Held

2.86M

Put Options Held

56.4K

View Full List

About Health Catalyst, Inc.

Ticker HCAT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 54,723,400
Market Cap $465M
Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...

More about HCAT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account